May 16-20: Who said What in Biotech and Pharmaceutical Industries?


These are some fresh promises that researchers and scientists made regarding their innovation and research and the collaborators filled us with the hope to take their business to a higher level and benefit the human race;


Quote 1.

Products that block PD-1/PD-L1 interactions are part of an evolving story about the relationship between the body’s immune system and its interaction with cancer cells”-Who said it? Answer is here

Quote 2.

Mission Pharmacal has a long history of dedication to the health and wellbeing of children. We understand the importance of providing a liquid form of potassium iodide that can help protect our nation’s most precious resource, our children, who are at greatest risk in the event of a nuclear emergency. The FDA’s approval of the ANDA for Potassium Iodide Oral Solution is yet another milestone for Mission Pharmacal in our long history and dedication to protecting young lives”-Who said it? Answer is here

Quote 3.

“Genome editing has broad applications in drug discovery and development and making the CRISPR-Cas9 patents available to biotechnology and pharmaceutical companies is an important part of our strategy”-Who said it? Answer is here

Quote 4.

Biogen views the development of gene editing technology as a natural extension of its current efforts to develop gene therapies employing viral and non-viral vectors”-Who said it? Answer is here

Quote 5.

Patients will readily attest to loss of mobility that is associated with degraded cartilage and the lengths they will go to try and alleviate often excruciating pain. We still have a long way to go before this technology reaches patients, but we’ve made some important steps in the right direction to move this technology towards the marketplace, which may ultimately provide relief to people around the world”-Who said it? Answer is here

Quote 6.

Lenvatinib plus everolimus is the first and only FDA-approved regimen that successfully combines treatments that employ tyrosine kinase and mTOR inhibition, the primary targets of advanced RCC treatment for the past decade”-Who said it? Answer is here

Quote 7.

“We have created an ecosystem which is a go-to platform for the participants of the pharmaceutical supply chain”-Who said it? Answer is here

Quote 8.

The NMI aims to advance understanding of microbiome behavior and enable protection and restoration of healthy microbiome function. In a year-long fact-finding process, scientists from Federal agencies, academia, and the private sector converged on three recommended areas of focus for microbiome science, which are now the goals of the NMI”-Who said it? Answer is here


Leave a reply

Your email address will not be published. Required fields are marked *